News

Haryana Govt, Deloitte Launch ‘Sanjeevani Pariyojana’ Virtual Home Care Initiative

delloite

The Government of Haryana, with support from Deloitte, has launched ‘Sanjeevani Pariyojana’ (The Life Project), a supervised, virtual home care initiative to help people quickly access healthcare for mild to moderate symptoms of Covid-19.

The approach taken by the Government of Haryana provides individuals with support and resources to manage their care at home, including access to virtual triage, as well as Covid-19 field hospitals and inpatient facilities when deemed appropriate by state-trained medical staff.

The Haryana-Deloitte collaboration builds on the state exists telemedicine and other virtual medical care services for home treatment.

The programme, designed and supported by Deloitte, the Public Health Foundation of India and the Post Graduate Institute of Medical Sciences (PGIMS-Haryana), is a “critically” important step in bringing much needed medical care to the people who need it most, when and where they need it most. The pilot project will begin in the district of Karnal and may include a roll out to other affected areas shortly thereafter.

Punit Renjen, Deloitte Global CEO, said: “Deloitte’s purpose is to make an impact that matters, and supporting the people of Haryana as the government delivers much-needed medical care to Covid-19 patients is one of the most important impacts we can make. This collaboration will ‘expand the medical ward’ by delivering help to those who can recover at home, thereby preserving capacity at larger hospitals to treat the critically ill. This approach was designed to be ‘fit for purpose’ and may yield a model to enable broader health equity and access to critical health resources in the region and beyond.”

‘Sanjeevani Pariyojana’ will also extend medical care to rural areas where awareness of the second wave of the virus and how to treat it remains low. With the right processes and care, officials believe it may be possible to support home convalescence for nearly 90% of patients.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top